Prurigo nodularis is a chronic dermatologic condition involving the development of multiple cutaneous nodules in the setting of intractable pruritus. Given emerging treatment options for this difficult-to-treat condition, a current review of therapeutics is needed. A systematic review was performed for ...
Precision Medicine and Biologics Rare Disease Wound Care Rosacea Psoriasis Psoriatic Arthritis Atopic Dermatitis Melasma NP and PA Skin Cancer Hidradenitis Suppurativa Drug Watch Pigmentary Disorders Acne Pediatric Dermatology Practice Management Prurigo Nodularis Buy-and-Bill Advertisement ...
A moderate to strong recommendation was given for the use of topical vitamin D in combination with corticosteroids and phototherapy in vitiligo and as monotherapy for various ichthyoses, morphea, pityriasis alba, prurigo nodularis, and polymorphous light eruption. There is evidence showing that topical...
[36]. The blood level of IL-31 is increased in many pruritic skin diseases including AD, cutaneous T cell lymphoma, uremic pruritus, chronic urticaria, and prurigo nodularis [37]. Furthermore, blood IL-31 level is correlated to disease severity in patients with AD [37]. In skin, ...
Prurigo nodularis produces intensely itchy bumps on the skin that arise for an unknown reason. There are several different treatments, and your Advanced Dermatology specialist can discuss them during your appointment. Keratoacanthomas Keratoacanthomas are low-grade tumors (growths with cells that look...
Prurigo nodularis is a chronic dermatologic condition involving the development of multiple cutaneous nodules in the setting of intractable pruritus. Given emerging treatment options for this difficult-to-treat condition, a current review of therapeutics is needed. A systematic review was performed for ...
Tissue damage caused by scratching may lead to acute conditions such as scratch prurigo (itchy wheals from scratching) or to the chronic lichenified patches of prurigo nodularis.doi:10.1007/978-3-642-57145-9_14Ing-Jun ChenSpringer Berlin Heidelberg...
Specifically, new therapies for inflammatory dermatoses, uremic pruritus, cholestatic pruritus, cutaneous T-cell lymphoma, and prurigo nodularis are being tested in ongoing randomized clinical trials. Compounds in development include neurokinin 1 receptor antagonists, anti-interleukin-31 receptor A ...